PNC Financial Services Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.7K | Buy |
2,192
+893
| +69% | +$38.6K | ﹤0.01% | 2743 |
|
|
2025
Q1 | $44.9K | Buy |
1,299
+200
| +18% | +$6.91K | ﹤0.01% | 3162 |
|
|
2024
Q4 | $30.2K | Sell |
1,099
-853
| -44% | -$23.4K | ﹤0.01% | 3351 |
|
|
2024
Q3 | $49.7K | Buy |
1,952
+1,114
| +133% | +$28.4K | ﹤0.01% | 3094 |
|
|
2024
Q2 | $21.2K | Buy |
838
+266
| +47% | +$6.74K | ﹤0.01% | 3450 |
|
|
2024
Q1 | $17.7K | Sell |
572
-25
| -4% | -$773 | ﹤0.01% | 3510 |
|
|
2023
Q4 | $24.1K | Sell |
597
-46
| -7% | -$1.86K | ﹤0.01% | 3330 |
|
|
2023
Q3 | $17K | Hold |
643
| – | – | ﹤0.01% | 3506 |
|
|
2023
Q2 | $11.1K | Hold |
643
| – | – | ﹤0.01% | 3835 |
|
|
2023
Q1 | $10.7K | Sell |
643
-116
| -15% | -$1.92K | ﹤0.01% | 3792 |
|
|
2022
Q4 | $5.78K | Buy |
759
+31
| +4% | +$236 | ﹤0.01% | 3958 |
|
|
2022
Q3 | $7K | Hold |
728
| – | – | ﹤0.01% | 3865 |
|
|
2022
Q2 | $7K | Buy |
728
+504
| +225% | +$4.85K | ﹤0.01% | 3899 |
|
|
2022
Q1 | $3K | Buy |
224
+142
| +173% | +$1.9K | ﹤0.01% | 4095 |
|
|
2021
Q4 | $1K | Sell |
82
-5,256
| -98% | -$64.1K | ﹤0.01% | 4256 |
|
|
2021
Q3 | $249K | Buy |
5,338
+144
| +3% | +$6.72K | ﹤0.01% | 2046 |
|
|
2021
Q2 | $316K | Sell |
5,194
-834
| -14% | -$50.7K | ﹤0.01% | 1929 |
|
|
2021
Q1 | $372K | Buy |
6,028
+1,832
| +44% | +$113K | ﹤0.01% | 1781 |
|
|
2020
Q4 | $299K | Buy |
4,196
+4,160
| +11,556% | +$296K | ﹤0.01% | 1820 |
|
|
2020
Q3 | $1K | Sell |
36
-5
| -12% | -$139 | ﹤0.01% | 3850 |
|
|
2020
Q2 | $1K | Buy |
+41
| New | +$1K | ﹤0.01% | 3830 |
|